{"id":3812,"date":"2017-01-20T12:26:11","date_gmt":"2017-01-20T12:26:11","guid":{"rendered":"https:\/\/www.wma.net\/wp-content\/uploads\/2017\/01\/Hurst_-__Vulnerability.pdf"},"modified":"2017-01-20T12:26:11","modified_gmt":"2017-01-20T12:26:11","slug":"hurst_-__vulnerability-2","status":"inherit","type":"attachment","link":"https:\/\/www.wma.net\/es\/hurst_-__vulnerability-2\/","title":{"rendered":"Hurst_-__Vulnerability"},"author":2,"comment_status":"open","ping_status":"closed","template":"","meta":[],"acf":[],"description":{"rendered":"<p class=\"attachment\"><a href='https:\/\/www.wma.net\/wp-content\/uploads\/2017\/01\/Hurst_-__Vulnerability.pdf'>Hurst_-__Vulnerability<\/a><\/p>\n<p>WMA expert conference on the Revision of the Declaration of Helsinki<br \/>\nCape Town, 5-7.12.2012<br \/>\nPr Samia Hurst, MD<br \/>\nInstitute for Biomedical Ethics<br \/>\nGeneva University Medical School<br \/>\nsamia.hurst@unige.ch<br \/>\nVulnerability<br \/>\nSome forms of vulnerability seem obvious<br \/>\nOthers are clearly not obvious<br \/>\nVulnerability<br \/>\n\u2022 Definitions and lists<br \/>\n\u2022 Problems<br \/>\n\u2022 Possible solutions<br \/>\nDefinitions<br \/>\nDeclaration of Helsinki (DoH), Paragraph 9<br \/>\n\u2018Some research populations are particularly vulnerable and need<br \/>\nspecial protection. These include\u2026\u2019<br \/>\nCIOMS, Commentary on Guideline 13<br \/>\n\u2018Vulnerable persons are those who are relatively (or absolutely)<br \/>\nincapable of protecting their own interests. More formally, they may<br \/>\nhave insufficient power, intelligence, education, resources, strength, or<br \/>\nother needed attributes to protect their own interest\u2019<br \/>\nICH-GCP (1.61) Vulnerable Subjects<br \/>\n\u2018Individuals whose willingness to volunteer in a clinical trial may be<br \/>\nunduly influenced by the expectation, whether justified or not, of<br \/>\nbenefits associated with participation, or of a retaliatory response from<br \/>\nsenior members of a hierarchy in case of refusal to participate\u2019<br \/>\nLists<br \/>\nDeclaration of Helsinki:<br \/>\n\u2026These include those who cannot give or refuse consent for<br \/>\nthemselves and those who may be vulnerable to coercion or undue<br \/>\ninfluence.<br \/>\nUS (Common Rule) 45 CFR 46:<br \/>\n&#8211; children, prisoners, pregnant women and foetuses<br \/>\nICH-GCP:<br \/>\n-members of a group with hierarchical structure (medical students,<br \/>\nhospital and laboratory personnel, employees in the pharmaceutical<br \/>\nindustry), unemployed or impoverished persons, ethnic minority group,<br \/>\nhomeless persons, nomads, refugees, minors<br \/>\nProblems<br \/>\nDefinitions:<br \/>\nIncomplete: incapacity to protect one\u2019s interests, susceptibility to coercion<br \/>\nLists:<br \/>\nAbsence of an explicit organizing principle leads to confusion (pregnancy<br \/>\ndoes not remove the capacity to consent for example)<br \/>\nIncompleteness, obsolescence, absurdity, labeling<br \/>\nGeneral:<br \/>\nLack of clarity as to what protection of vulnerable persons mean,<br \/>\npotentially counterproductive effects.<br \/>\nDeclaration of Helsinki<br \/>\nParagraph 9<br \/>\n\u2018Some research populations are particularly vulnerable and need<br \/>\nspecial protection. These include those who cannot give or refuse<br \/>\nconsent for themselves and those who may be vulnerable to coercion<br \/>\nor undue influence.\u2019<br \/>\nParagraph 16<br \/>\nThe responsibility for the protection of research subjects must always<br \/>\nrest with the physician or other health care professional and never the<br \/>\nresearch subjects, even though they have given consent.<br \/>\nInconsistent<br \/>\nImplicitly states \u2013 without justification- that vulnerability is<br \/>\ninherently based on a deficit on the part of the vulnerable person.<br \/>\nOptions<br \/>\nDissolve: Vulnerability is a matter of degree. The same protections<br \/>\nshould apply. Although they will require greater effort, this does not<br \/>\nrequire any additional principles.<br \/>\nProblem: invisibility, inappropriate uniformity in protocol design and<br \/>\nREC review.<br \/>\nList: Attempt to devise a list of vulnerable groups or persons which<br \/>\nadheres to an appropriate \u2013and explicit- organizing principle.<br \/>\nProblem: \u2026 incompleteness, obsolescence, absurdity, labeling<br \/>\nInstruct: provide clarification of vulnerability and the required<br \/>\nprotections.<br \/>\nVulnerability<br \/>\nHurst S.: Vulnerability in Research and Health Care; Describing the Elephant in the<br \/>\nRoom? Bioethics. 2008; 22(4):191-202<br \/>\nA greater likelihood of incurring a wrong in the context of research.<br \/>\nAny wrong. For any reason.<br \/>\n9. Medical research is subject to ethical standards that promote<br \/>\nrespect for all human subjects and protect their health and rights.<br \/>\nSome research populations are particularly vulnerable and need<br \/>\nspecial protection. These include those who cannot give or<br \/>\nrefuse consent for themselves and those who may be vulnerable<br \/>\nto coercion or undue influence.<br \/>\n9. Medical research is subject to ethical standards that promote<br \/>\nrespect for all human subjects and protect their health and rights.<br \/>\nSome research populations are particularly vulnerable and need<br \/>\nspecial protection. These include those who cannot give or<br \/>\nrefuse consent for themselves and those who may be vulnerable<br \/>\nto coercion or undue influence.<br \/>\n9. Medical research is subject to ethical standards that promote<br \/>\nrespect for all human subjects and protect their health and rights.<br \/>\nSome research populations are particularly vulnerable and need<br \/>\nspecial protection. These include those who cannot give or<br \/>\nrefuse consent for themselves and those who may be vulnerable<br \/>\nto coercion or undue influence. The responsibility for the<br \/>\nprotection of research subjects must always rest with the<br \/>\nphysician or other health care professional and never the<br \/>\nresearch subjects, even though they have given consent.<br \/>\n9. Medical research is subject to ethical standards that promote<br \/>\nrespect for all human subjects and protect their health and rights.<br \/>\nSome research populations are particularly vulnerable and need<br \/>\nspecial protection. These include those who cannot give or<br \/>\nrefuse consent for themselves and those who may be vulnerable<br \/>\nto coercion or undue influence. The responsibility for the<br \/>\nprotection of research subjects must always rest with the<br \/>\nphysician or other health care professional investigators and<br \/>\nnever the research subjects, even though they have given<br \/>\nconsent.<br \/>\n9. Medical research is subject to ethical standards that promote<br \/>\nrespect for all human subjects and protect their health and rights.<br \/>\nSome research populations are particularly vulnerable and need<br \/>\nspecial protection. These include those who cannot give or<br \/>\nrefuse consent for themselves and those who may be vulnerable<br \/>\nto coercion or undue influence. The responsibility for the<br \/>\nprotection of research subjects must always rest with the<br \/>\nphysician or other health care professional investigators and<br \/>\nnever the research subjects, even though they have given<br \/>\nconsent. This implies a duty to guarantee equal protection for<br \/>\nvulnerable participants, whose health and rights are more<br \/>\ndifficult to protect.<br \/>\n9. Medical research is subject to ethical standards that promote<br \/>\nrespect for all human subjects and protect their health and rights.<br \/>\nThe responsibility for the protection of research subjects must<br \/>\nalways rest with the investigators and never the research<br \/>\nsubjects. This implies a duty to guarantee equal protection for<br \/>\nvulnerable participants, whose health and rights are more<br \/>\ndifficult to protect.<br \/>\n9. Medical research is subject to ethical standards that promote<br \/>\nrespect for all human subjects and protect their health and rights.<br \/>\nThe responsibility for the protection of research subjects must<br \/>\nalways rest with the investigators and never the research<br \/>\nsubjects. This implies a duty to guarantee equal protection for<br \/>\nvulnerable participants, whose health and rights are more<br \/>\ndifficult to protect.<br \/>\n16. Researchers\u2019 Ethical Obligations:<br \/>\n16.0: Researchers have an obligation to implement the principles<br \/>\ncontained in the present declaration at all stages of research.<br \/>\nThis implies a duty to guarantee equal protection for vulnerable<br \/>\nparticipants, whose health and rights are more difficult to protect.<br \/>\nPossible concerns<br \/>\nVirtually all studies will recruit vulnerable persons<br \/>\nWe lose subsidiarity<br \/>\nWe lose protections associated with REC structure<br \/>\nThis is not per se a problem, if the protections extended to them are appropriate.<br \/>\nProtection against being recruited in exploitative research is required for all<br \/>\nAs is protection against non-existence of research targeting one\u2019s needs<br \/>\nProtection against conflicts of interests in RECs should also apply to everyone.<br \/>\nProtection against sloppy protections is easier with clearer standards<br \/>\nConclusion<br \/>\n\u2022 Don\u2019t list the vulnerable<br \/>\n\u2022 Provide a clear guidance: vulnerability is a matter of degree.<br \/>\n\u2013 Protecting vulnerability implies a duty to guarantee equal<br \/>\nprotection for vulnerable participants, whose health and rights<br \/>\nare more difficult to protect<br \/>\n\u2022 Stick to the general guidance: require a case by case<br \/>\nspecification but don\u2019t do it within the DoH.<br \/>\n\u2022 As far as vulnerabiliy is concerned, scrap the rest: all other<br \/>\nso-called protections of vulnerability should really apply to<br \/>\neveryone.<\/p>\n"},"caption":{"rendered":"<p>Hurst_-__Vulnerability WMA expert conference on the Revision of the Declaration of Helsinki Cape Town, 5-7.12.2012 Pr Samia Hurst, MD Institute for Biomedical Ethics Geneva University Medical School samia.hurst@unige.ch Vulnerability Some forms of vulnerability seem obvious Others are clearly not obvious Vulnerability \u2022 Definitions and lists \u2022 Problems \u2022 Possible solutions Definitions Declaration of Helsinki (DoH), [&hellip;]<\/p>\n"},"alt_text":"","media_type":"file","mime_type":"application\/pdf","media_details":{},"post":null,"source_url":"https:\/\/www.wma.net\/wp-content\/uploads\/2017\/01\/Hurst_-__Vulnerability.pdf","_links":{"self":[{"href":"https:\/\/www.wma.net\/es\/wp-json\/wp\/v2\/media\/3812"}],"collection":[{"href":"https:\/\/www.wma.net\/es\/wp-json\/wp\/v2\/media"}],"about":[{"href":"https:\/\/www.wma.net\/es\/wp-json\/wp\/v2\/types\/attachment"}],"author":[{"embeddable":true,"href":"https:\/\/www.wma.net\/es\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.wma.net\/es\/wp-json\/wp\/v2\/comments?post=3812"}]}}